Background. The coronavirus disease 2019 (COVID-19) started in December 2019 in Wuhan. This study evaluated clinical characteristics, and imaging manifestations in Ezhou, an early locked down city, about 36 miles east of Wuhan where the outbreaks started. Methods. We analyzed data from 98 confirmed severe COVID-19 patients in Ezhou Central Hospital between February 1st and March 22nd, 2020. We compared patients’ laboratory results, imaging manifestations and treatments between survival and death groups. Results. Of these 98 confirmed COVID-19 patients, 24 individuals (24.6%) had chronic diseases, such as cardiovascular disease and chronic respiratory disease. The main symptoms of critically ill patients were fever (86.7%), cough (83.7%), an...
To assess imaging data in COVID-19 patients and its association with clinical course and survival an...
Objective. To explore the clinical characteristics of patients with different severity in the early ...
Coronavirus disease 2019 (COVID-19) was first identified in Wuhan, China, in December 2019. Although...
BACKGROUND:Since the first case of a coronavirus disease 2019 (COVID-19) infection pneumonia was det...
Coronavirus disease (COVID-19) started as a cluster of pneumonia cases in December 2019 and has rapi...
2019 novel coronavirus disease (COVID-19, previously known as novel coronavirus pneumonia) was first...
BackgroundAs the current outbreak of COVID-2019 disease has spread to the other more than 150 countr...
Radiologic characteristics of 2019 novel coronavirus (2019-nCoV) infected pneumonia (NCIP) which had...
Coronavirus disease 2019 (COVID-19) was discovered after unusual cases of severe pneumonia emerged i...
COVID-19 is a newly emerged pandemic with great worldwide challenges. Imaging features are one of th...
Radiologic characteristics of 2019 novel coronavirus (2019-nCoV) infected pneumonia (NCIP) which had...
Aim: In this study, we aimed to investigate early predictors of critical illness and mortality in pa...
Coronavirus disease 2019 (COVID-19) has caused considerable morbidity and mortality worldwide since ...
The Coronavirus Disease 2019 (COVID-19) represents the first medical catastrophe of the new millenni...
Background: So far, only a few studies evaluated the correlation between CT features and clinical ou...
To assess imaging data in COVID-19 patients and its association with clinical course and survival an...
Objective. To explore the clinical characteristics of patients with different severity in the early ...
Coronavirus disease 2019 (COVID-19) was first identified in Wuhan, China, in December 2019. Although...
BACKGROUND:Since the first case of a coronavirus disease 2019 (COVID-19) infection pneumonia was det...
Coronavirus disease (COVID-19) started as a cluster of pneumonia cases in December 2019 and has rapi...
2019 novel coronavirus disease (COVID-19, previously known as novel coronavirus pneumonia) was first...
BackgroundAs the current outbreak of COVID-2019 disease has spread to the other more than 150 countr...
Radiologic characteristics of 2019 novel coronavirus (2019-nCoV) infected pneumonia (NCIP) which had...
Coronavirus disease 2019 (COVID-19) was discovered after unusual cases of severe pneumonia emerged i...
COVID-19 is a newly emerged pandemic with great worldwide challenges. Imaging features are one of th...
Radiologic characteristics of 2019 novel coronavirus (2019-nCoV) infected pneumonia (NCIP) which had...
Aim: In this study, we aimed to investigate early predictors of critical illness and mortality in pa...
Coronavirus disease 2019 (COVID-19) has caused considerable morbidity and mortality worldwide since ...
The Coronavirus Disease 2019 (COVID-19) represents the first medical catastrophe of the new millenni...
Background: So far, only a few studies evaluated the correlation between CT features and clinical ou...
To assess imaging data in COVID-19 patients and its association with clinical course and survival an...
Objective. To explore the clinical characteristics of patients with different severity in the early ...
Coronavirus disease 2019 (COVID-19) was first identified in Wuhan, China, in December 2019. Although...